HIV-Related Opportunistic Diseases

Total Page:16

File Type:pdf, Size:1020Kb

HIV-Related Opportunistic Diseases HIV-related opportunistic diseases UNAIDS Technical update October 1998 UNAIDS Best Practice Collection At a Glance UNAIDS Best Practice materials The Joint United Nations Programme on HIV/AIDS (UNAIDS) is preparing materials on subjects of relevance to HIV infection and AIDS, the causes and consequences of the epidemic, and best practices Opportunistic diseases in a person with HIV are the products of two in AIDS prevention, care and things: the person’s lack of immune defences caused by the virus, support. A Best Practice Collection and the presence of microbes and other pathogens in our everyday on any one subject typically environment. includes a short publication for journalists and community leaders A partial list of the world’s most common opportunistic diseases and diseases includes: (Point of View); atechnical summary of the issues, challenges and • bacterial diseases such as tuberculosis (TB, caused by Mycobacterium solutions (Technical Update); case tuberculosis), Mycobacterium avium complex disease (MAC), bacterial studies from around the world (Best pneumonia and septicaemia (“blood poisoning”) Practice Case Studies); a set of • protozoal diseases such as Pneumocystis carinii pneumonia (PCP), presentation graphics; and a listing toxoplasmosis, microsporidiosis, cryptosporidiosis, isosporiasis and of key materials (reports, articles, leishmaniasis books, audiovisuals, etc.) on the • fungal diseases such as candidiasis, cryptococcosis (cryptococcal subject. These documents are meningitis (CRM)) and penicilliosis updated as necessary. • viral diseases such as those caused by cytomegalovirus (CMV), Technical Updates and Points herpes simplex and herpes zoster virus ofView are being published in • HIV-associated malignancies such as Kaposi sarcoma, lymphoma English, French, Russian and and squamous cell carcinoma. Spanish. Single copies of Best Practice materials are available Effective intervention against opportunistic diseases requires not only the appropriate drug or other medications for a given medical condition, freefrom UNAIDS Information but also the infrastructure necessary to diagnose the condition, monitor Centres. To find the closest one, the intervention, and counsel patients. As well, use of drugs and tests visitUNAIDS on the Internet must be supported by proper storage, handling and administrative (http://www.unaids.org), contact procedures. UNAIDS by email ([email protected]) or telephone (+41 22 791 4651), The main challenge of choosing between interventions is to alleviate orwrite to the UNAIDS Information the morbidity and suffering of those in need while not exceeding the Centre, 20 Avenue Appia, financial and technical capabilities of the health system. Unfortunately, 1211Geneva 27, Switzerland. these choices often need to be made without the help of formal cost-benefit and cost-effectiveness analyses. This is partly because the information needed to calculate costs is difficult to collect, but also because benefits other than short-term improvements in quality HIV-related opportunistic diseases: of life are not well understood or easily quantified. UNAIDS Technical Update. October 1998. In places where resources are very scarce, priority should be given to I. UNAIDS II. Series health needs shared by most or all of the population, including those who are HIV-infected. Examples are drugs to relieve pain in terminal 1. AIDS-related opportunistic patients—including those with AIDS—or for TB. Drugs to treat and infections—drug therapy prevent TB have a high overall value to society in many countries 2. AIDS-related opportunistic because they (a) benefit people affected by two epidemics (HIV/AIDS infections—diagnosis and TB), (b) are proven effective and (c) are relatively inexpensive 3. Prevalence given the number of people who can benefit. 4. Drug therapy—economics 5. Diagnosic services Only a few opportunistic diseases and symptoms such as oropharyngeal 6. Cost of illness and vaginal candidiasis (“thrush”) or herpes zoster and herpes simplex 7. Health priorities can be managed effectively through home-based care. Most other UNAIDS, Geneva opportunistic diseases require diagnosis and treatment which are WC 503.5 beyond the capabilities of most community-based groups and NGOs. For conditions that can be treated only at a very high cost, the public- health rationale for treatment is weaker, and humanitarian or equity considerations become more important. Examples of such conditions are CMV, MAC, cryptococcal meningitis (CRM), penicilliosis and rarer systemic mycoses. 2 October 1998 HIV-related opportunistic diseases: UNAIDS Technical Update Background People with advanced HIV infection are vulnerable to infections or malignancies that are called “opportunistic” because they take advantage of the opportunity offered by a weakened immune system. Various treatments and prophylaxis—some simple and low-cost, others highly complex and expensive—exist to counter the most common opportunistic diseases, but delivery systems and funding are insufficient in many parts of the world to ensure their universal use. The worldwide distribution of itraconazole, fluconazole or efficacy at a relatively high cost opportunistic diseases is highly amphotericin B. A two-week (which is increased by the need for varied. Table 1 shows data on their course of ketoconazole 200 mg close monitoring), and are not distribution in six countries from costs US$ 5.53. Other azole included in the WHO essential Africa, the Americas, and South- antifungal agents are not available drugs list. East Asia. Like the following brief through generics suppliers, and are overview of the most common much more expensive. Herpes simplex diseases and the interventions and Herpes zoster available for their treatment Cryptococcosis Herpes simplex virus infection or prevention, the table is only Systemic mycoses such as crypto- (HSV, which causes sores around intended to give a sense of the coccosis probably cause about the mouth and genitals) and herpes wide differences from country 5% of all HIV-associated deaths zoster virus infection (“zonal” herpes) to country. worldwide. Cryptococcosis most are not life-threatening but can be Table 2 provides a comparison of often appears as meningitis, and extremely painful. Both occur costs of treatment and prophylaxis occasionally as pulmonary or frequently in HIV-infected persons, for the most common opportunistic disseminated disease. Cryptococcal but as they are not considered diseases. meningitis (CRM) is the most AIDS-defining conditions there are frequent systemic fungal infection few data about their incidence. Candidiasis in HIV-infected persons. Without Note, however, that both can treatment, life expectancy is cause encephalitis, which can be The two main types of candidiasis probably less than a month. life-threatening. are localized disease (of the mouth and throat, and of the vagina), Cryptococcosis is relatively easy Treatment with aciclovir is only and systemic disease (of the to diagnose. However, its treat- marginally effective in herpes oesophagus, and disseminated ment (either amphotericin B with zoster but is sometimes dramatic disease). The mouth and throat or without flucytosine, or in mild in HIV-associated herpes simplex variant (oropharyngeal candidiasis cases with oral fluconazole) and with extensive ulceration. Aciclovir or OPC) is believed to occur at secondary chemoprophylaxis are is expensive, costing US$ 45.82 least once in the lifetime in all often impossible in developing and US$ 170.18 for 5-day herpes HIV-infected patients. countries because of the high simplex and 7-day herpes zoster cost and limited availability of regimens respectively. However, While OPC is not a cause of death, the drugs required. its cost is likely to decrease when it causes oral pain and makes it is no longer protected by patent, swallowing difficult. The symptom Cytomegalovirus infection (CMV) as is the case in the United Kingdom of oesophageal candidiasis is pain where generic aciclovir is available. in the chest that increases with Estimates of the incidence of CMV Aciclovir can also be used to treat swallowing, and difficulty in disease vary considerably between encephalitis at a cost of US$ 1282.76 swallowing. Disseminated geographical locations, but CMV for a ten-day intravenous regimen. candidiasis causes fever and causes significant suffering in HIV- symptoms in the organs affected by infected persons worldwide. Kaposi sarcoma the disease (for example, blind- Symptoms include fever and HIV-associated Kaposi sarcoma ness when it affects the eyes). diarrhoea from CMV colitis, dyspnoea causes dark blue lesions which Localized disease is treated first from CMV pneumonitis, and can occur in a variety of locations with relatively inexpensive topical blindness caused by CMV retinitis. including the skin, mucous membranes, gastrointestinal tract, drugs such as nystatin, miconazole, Treatment aims to alleviate lungs or lymph nodes. The lesions or clotrimazole. Systemic anti- symptoms, and to prevent blindness, usually appear early in the course fungals agents are usually given rather than provide a cure. The only when topical therapy fails. of HIV infection. drugs currently used are ganciclovir Systemic candidiasis requires and foscarnet, with cidofovir when Treatment depends on the lesions’ treatment with systemic antifungal the first two have failed. They symptoms and location. For local agents such as ketoconazole, have high toxicity and limited lesions, injection therapy with 3 HIV-related opportunistic
Recommended publications
  • And Toxoplasmosis in Jackass Penguins in South Africa
    IMMUNOLOGICAL SURVEY OF BABESIOSIS (BABESIA PEIRCEI) AND TOXOPLASMOSIS IN JACKASS PENGUINS IN SOUTH AFRICA GRACZYK T.K.', B1~OSSY J.].", SA DERS M.L. ', D UBEY J.P.···, PLOS A .. ••• & STOSKOPF M. K .. •••• Sununary : ReSlIlIle: E x-I1V\c n oN l~ lIrIUSATION D'Ar\'"TIGENE DE B ;IB£,'lA PH/Re El EN ELISA ET simoNi,cATIVlTli t'OUR 7 bxo l'l.ASMA GONIJfI DE SI'I-IENICUS was extracted from nucleated erythrocytes Babesia peircei of IJEMIiNSUS EN ArRIQUE D U SUD naturally infected Jackass penguin (Spheniscus demersus) from South Africo (SA). Babesia peircei glycoprotein·enriched fractions Babesia peircei a ele extra it d 'erythrocytes nue/fies p,ovenanl de Sphenicus demersus originoires d 'Afrique du Sud infectes were obto ined by conca navalin A-Sepharose affinity column natulellement. Des fractions de Babesia peircei enrichies en chromatogrophy and separated by sod ium dodecyl sulphate­ glycoproleines onl ele oblenues par chromatographie sur colonne polyacrylam ide gel electrophoresis (SDS-PAGE ). At least d 'alfinite concona valine A-Sephorose et separees par 14 protein bonds (9, 11, 13, 20, 22, 23, 24, 43, 62, 90, electrophorese en gel de polyacrylamide-dodecylsuJfale de sodium 120, 204, and 205 kDa) were observed, with the major protein (SOS'PAGE) Q uotorze bandes proleiques au minimum ont ete at 25 kDa. Blood samples of 191 adult S. demersus were tes ted observees (9, 1 I, 13, 20, 22, 23, 24, 43, 62, 90, 120, 204, by enzyme-linked immunosorbent assoy (ELISA) utilizing B. peircei et 205 Wa), 10 proleine ma;eure elant de 25 Wo.
    [Show full text]
  • Neglected Parasitic Infections in the United States Toxoplasmosis
    Neglected Parasitic Infections in the United States Toxoplasmosis Toxoplasmosis is a preventable disease caused by the parasite Toxoplasma gondii. An infected individual can experience fever, malaise, and swollen lymph nodes, but can also show no signs or symptoms. A small number of infected persons may experience eye disease, and infection during pregnancy can lead to miscarriage or severe disease in the newborn, including developmental delays, blindness, and epilepsy. Once infected with T. gondii, people are generally infected for life. As a result, infected individuals with weakened immune systems—such as in the case of advanced HIV disease, during cancer treatment, or after organ transplant—can experience disease reactivation, which can result in severe illness or even death. In persons with advanced HIV disease, inflammation of the brain (encephalitis) due to toxoplasmosis is common unless long-term preventive medication is taken. Researchers have also found an association of T. gondii infection with the risk for mental illness, though this requires further study. Although T. gondii can infect most warm-blooded animals, cats are the only host that shed an environmentally resistant form of the organism (oocyst) in their feces. Once a person or another warm-blooded animal ingests the parasite, it becomes infectious and travels through the wall of the intestine. Then the parasite is carried by blood to other tissues including the muscles and central nervous system. Humans can be infected several ways, including: • Eating raw or undercooked meat containing the parasite in tissue cysts (usually pork, lamb, goat, or wild game meat, although beef and field-raised chickens have been implicated in studies).
    [Show full text]
  • Oxidative Stress As a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities
    International Journal of Molecular Sciences Review Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities Karolina Szewczyk-Golec , Marta Pawłowska , Roland Wesołowski , Marcin Wróblewski and Celestyna Mila-Kierzenkowska * Department of Medical Biology and Biochemistry, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru´n,24 Karłowicza St, 85-092 Bydgoszcz, Poland; [email protected] (K.S.-G.); [email protected] (M.P.); [email protected] (R.W.); [email protected] (M.W.) * Correspondence: [email protected]; Tel.: +48-52-585-37-37 Abstract: Toxoplasma gondii is an apicomplexan parasite causing toxoplasmosis, a common disease, which is most typically asymptomatic. However, toxoplasmosis can be severe and even fatal in immunocompromised patients and fetuses. Available treatment options are limited, so there is a strong impetus to develop novel therapeutics. This review focuses on the role of oxidative stress in the pathophysiology and treatment of T. gondii infection. Chemical compounds that modify redox status can reduce the parasite viability and thus be potential anti-Toxoplasma drugs. On the other hand, oxidative stress caused by the activation of the inflammatory response may have some deleterious consequences in host cells. In this respect, the potential use of natural antioxidants Citation: Szewczyk-Golec, K.; is worth considering, including melatonin and some vitamins, as possible novel anti-Toxoplasma Pawłowska, M.; Wesołowski, R.; therapeutics. Results of in vitro and animal studies are promising. However, supplementation with Wróblewski, M.; Mila-Kierzenkowska, some antioxidants was found to promote the increase in parasitemia, and the disease was then C.
    [Show full text]
  • Control of Intestinal Protozoa in Dogs and Cats
    Control of Intestinal Protozoa 6 in Dogs and Cats ESCCAP Guideline 06 Second Edition – February 2018 1 ESCCAP Malvern Hills Science Park, Geraldine Road, Malvern, Worcestershire, WR14 3SZ, United Kingdom First Edition Published by ESCCAP in August 2011 Second Edition Published in February 2018 © ESCCAP 2018 All rights reserved This publication is made available subject to the condition that any redistribution or reproduction of part or all of the contents in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise is with the prior written permission of ESCCAP. This publication may only be distributed in the covers in which it is first published unless with the prior written permission of ESCCAP. A catalogue record for this publication is available from the British Library. ISBN: 978-1-907259-53-1 2 TABLE OF CONTENTS INTRODUCTION 4 1: CONSIDERATION OF PET HEALTH AND LIFESTYLE FACTORS 5 2: LIFELONG CONTROL OF MAJOR INTESTINAL PROTOZOA 6 2.1 Giardia duodenalis 6 2.2 Feline Tritrichomonas foetus (syn. T. blagburni) 8 2.3 Cystoisospora (syn. Isospora) spp. 9 2.4 Cryptosporidium spp. 11 2.5 Toxoplasma gondii 12 2.6 Neospora caninum 14 2.7 Hammondia spp. 16 2.8 Sarcocystis spp. 17 3: ENVIRONMENTAL CONTROL OF PARASITE TRANSMISSION 18 4: OWNER CONSIDERATIONS IN PREVENTING ZOONOTIC DISEASES 19 5: STAFF, PET OWNER AND COMMUNITY EDUCATION 19 APPENDIX 1 – BACKGROUND 20 APPENDIX 2 – GLOSSARY 21 FIGURES Figure 1: Toxoplasma gondii life cycle 12 Figure 2: Neospora caninum life cycle 14 TABLES Table 1: Characteristics of apicomplexan oocysts found in the faeces of dogs and cats 10 Control of Intestinal Protozoa 6 in Dogs and Cats ESCCAP Guideline 06 Second Edition – February 2018 3 INTRODUCTION A wide range of intestinal protozoa commonly infect dogs and cats throughout Europe; with a few exceptions there seem to be no limitations in geographical distribution.
    [Show full text]
  • No Association Between Current Depression and Latent Toxoplasmosis in Adults
    Institute of Parasitology, Biology Centre CAS Folia Parasitologica 2016, 63: 032 doi: 10.14411/fp.2016.032 http://folia.paru.cas.cz Research Article No association between current depression and latent toxoplasmosis in adults Shawn D. Gale1,2, Andrew N. Berrett1, Bruce Brown1, Lance D. Erickson3 and Dawson W. Hedges1,2 1 Department of Psychology, Brigham Young University, Provo, Utah, USA; 2 The Neuroscience Center, Brigham Young University, Provo, Utah, USA; 3 Department of Sociology, Brigham Young University, Provo, Utah, USA Abstract: Changes in behaviour and cognition have been associated with latent infection from the apicomplexan protozoan Toxoplas- ma gondii (Nicolle et Manceaux, 1908) in both animal and human studies. Further, neuropsychiatric disorders such as schizophrenia have also been associated with latent toxoplasmosis. Previously, we found no association between T. gondii immunoglobulin G anti- body (IgG) seropositivity and depression in human adults between the ages of 20 and 39 years (n = 1 846) in a sample representative of the United States collected by the Centers for Disease Control as part of a National Health and Nutrition Examination Survey (NHANES) from three datasets collected between 1999–2004. In the present study, we used NHANES data collected between 2009 and 2012 that included subjects aged 20 to 80 years (n = 5 487) and used the Patient Health Questionnaire 9 (PHQ-9) to assess depres- sion with the overall aim of testing the stability of the results of the prior study. In the current study, the seroprevalence of T. gondii was 13%. The percentage of subjects reporting clinical levels of depression assessed with the PHQ-9 was 8%.
    [Show full text]
  • Sero Burden of Toxoplasma Gondii and Associated Risk Factors Among HIV Infected Persons in Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia
    iseas al D es ic & p P u ro b T l f i c o l H a e Journal of Tropical Diseases and Public a n r l t u h o J ISSN: 2329-891X Health Research Article Sero Burden of Toxoplasma gondii and Associated Risk Factors among HIV Infected Persons in Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia Fewzia Mohammed1,2*, Mulusew Alemneh Sinishaw3,4, Negash Nurahmed1, Shemsu Kedir Juhar1, Kassu Desta5 1Ethiopian Public Health Institute, Addis Ababa, Ethiopia; 2Armed forces Referral and Teaching Hospital, Addis Ababa, Ethiopia; 3Clinical Chemistry Department, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; 4Clinical Chemistry Department, Amhara Public Health Institute, Bahir Dar, Ethiopia; 5School of Allied Health Science, Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia ABSTRACT Background: Toxoplasmosis is a zoonotic disease, worldwide distribution caused by an obligate intracellular coccidian parasite, known as Toxoplasma gondii. T. gondii can lead to serious diseases in immuno-compromised patients such as HIV/AIDS patients. In most cases, central nervous system involvement can lead to encephalitis, which is one of the most important reasons for death among patients with HIV due to reactivation of tissue cysts that remained latent after the primary infection. This study was conducted to assess the sero burden of Toxoplasma gondii infection and identify associated risk factors among HIV infected individuals in Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia. Methods: A cross-sectional study was conducted from March to May 2016. After getting an informed consent a pretested questionnaire was used to gather socio-demographic information and data on factors predisposing to T.
    [Show full text]
  • Cyclosporiasis: an Update
    Cyclosporiasis: An Update Cirle Alcantara Warren, MD Corresponding author Epidemiology Cirle Alcantara Warren, MD Cyclosporiasis has been reported in three epidemiologic Center for Global Health, Division of Infectious Diseases and settings: sporadic cases among local residents in an International Health, University of Virginia School of Medicine, MR4 Building, Room 3134, Lane Road, Charlottesville, VA 22908, USA. endemic area, travelers to or expatriates in an endemic E-mail: [email protected] area, and food- or water-borne outbreaks in a nonendemic Current Infectious Disease Reports 2009, 11:108–112 area. In tropical and subtropical countries (especially Current Medicine Group LLC ISSN 1523-3847 Haiti, Guatemala, Peru, and Nepal) where C. cayetanen- Copyright © 2009 by Current Medicine Group LLC sis infection is endemic, attack rates appear higher in the nonimmune population (ie, travelers, expatriates, and immunocompromised individuals). Cyclosporiasis was a Cyclosporiasis is a food- and water-borne infection leading cause of persistent diarrhea among travelers to that affects healthy and immunocompromised indi- Nepal in spring and summer and continues to be reported viduals. Awareness of the disease has increased, and among travelers in Latin America and Southeast Asia outbreaks continue to be reported among vulnera- [8–10]. Almost half (14/29) the investigated Dutch attend- ble hosts and now among local residents in endemic ees of a scientifi c meeting of microbiologists held in 2001 areas. Advances in molecular techniques have in Indonesia had C. cayetanensis in stool, confi rmed by improved identifi cation of infection, but detecting microscopy and/or polymerase chain reaction (PCR), and food and water contamination remains diffi cult.
    [Show full text]
  • Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
    International Journal of Molecular Sciences Review Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses Tanja Becker, Vu Thuy Khanh Le-Trilling and Mirko Trilling * Institute for Virology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany; [email protected] (T.B.); [email protected] (V.T.K.L.-T.) * Correspondence: [email protected]; Tel.: +49-(0)201-723-83830 Received: 15 March 2019; Accepted: 28 March 2019; Published: 2 April 2019 Abstract: Human cytomegalovirus (HCMV) is a ubiquitous betaherpesvirus that frequently causes morbidity and mortality in individuals with insufficient immunity, such as transplant recipients, AIDS patients, and congenitally infected newborns. Several antiviral drugs are approved to treat HCMV infections. However, resistant HCMV mutants can arise in patients receiving long-term therapy. Additionally, side effects and the risk to cause birth defects limit the use of currently approved antivirals against HCMV. Therefore, the identification of new drug targets is of clinical relevance. Recent work identified DNA-damage binding protein 1 (DDB1) and the family of the cellular cullin (Cul) RING ubiquitin (Ub) ligases (CRLs) as host-derived factors that are relevant for the replication of human and mouse cytomegaloviruses. The first-in-class CRL inhibitory compound Pevonedistat (also called MLN4924) is currently under investigation as an anti-tumor drug in several clinical trials. Cytomegaloviruses exploit CRLs to regulate the abundance of viral proteins, and to induce the proteasomal degradation of host restriction factors involved in innate and intrinsic immunity. Accordingly, pharmacological blockade of CRL activity diminishes viral replication in cell culture.
    [Show full text]
  • Food and Waterborne Parasitology 16 (2019) E00058
    Food and Waterborne Parasitology 16 (2019) e00058 Contents lists available at ScienceDirect Food and Waterborne Parasitology journal homepage: www.elsevier.com/locate/fawpar Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings Branko Bobić a,⁎, Isabelle Villena b, Eileen Stillwaggon c a Institute for Medical Research, University of Belgrade, Centre of Excellence for Food- and Vector-borne Zoonoses, National Reference Laboratory for Toxoplasmosis, Serbia b EA 7510, UFR Médecine, University Reims Champagne-Ardenne, National Reference Center on Toxoplasmosis, Hospital Reims, France c Department of Economics, Gettysburg College, Gettysburg, PA, USA article info abstract Article history: Congenital toxoplasmosis (CT), the result of a primary infection of pregnant women with Toxo- Received 20 December 2018 plasma gondii which was transmitted to the fetus, may result in mild to deep injuries occurring Received in revised form 13 May 2019 in the newborn or later in its development or in adolescence. The visual and cognitive impair- Accepted 13 May 2019 ment that can result imposes substantial economic costs on the individual and society. Numer- Available online xxxx ous observational studies favor the conclusion that, with preventive measures currently available, it is possible to reduce the incidence of infections in pregnant women, the incidence Keywords: of fetal infection by preventing transplacental transmission, and the gravity of injury in infected Congenital toxoplasmosis newborns. Treatment of infected newborns can also reduce the severity of consequences and Prevention the frequency of their occurrence later in life. Prevention programs, however, are applied in Screening Economic costs only a few countries; in most countries implementation of a national prevention program Economic benefits has not been considered or has been thought to be too expensive.
    [Show full text]
  • Identification of Cyclospora and Isospora from Diarrheic Patients in the Philippines
    Philippine Journal of Science RESEARCH NOTE 137 (1): 11-15, June 2008 ISSN 0031 - 7683 Identification of Cyclospora and Isospora from Diarrheic Patients in the Philippines Corazon C. Buerano1,2, Catherine B. Lago1, Ronald R. Matias1, Blanquita B. de Guzman1, Shinji Izumiyama3, Kenji Yagita3, and Filipinas F. Natividad1* 1Research and Biotechnology Division, St. Luke’s Medical Center 279 E. Rodriguez Sr. Ave., Quezon City 1102, Philippines 2Institute of Biology, University of the Philippines Diliman, Quezon City 1101, Philippines 3Department of Parasitology, National Institute of Infectious Diseases Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan In recent years, Cyclospora cayetanensis and Isospora belli have been recognized as causative organisms in cases of chronic diarrhea. The aim of this study was undertaken to determine the prevalence of enteric protozoa among diarrhea patients in the Philippines. Stools were collected and from 3456 samples examined, only one sample each was found positive for oocysts of Cyclospora cayetanensis and Isospora belli. Identification was based on autofluorescence of the oocysts with a 365 nm ultraviolet excitation filter. Both samples were obtained from male patients (18 and 73 years old, respectively) living in Iloilo province in the western islands of Visayas, Philippines. Both patients obtained their drinking water from deep wells. The identification of these two emerging pathogens, which are easily overlooked by less-trained technical staff, highlights the increasing awareness and technical capability on detecting these parasites in the Philippines. Key Words: Cyclospora, Isospora, enteric protozoa, diarrhea INTRODUCTION in tropical areas of south America and southeast Asia (Wittner et al. 1993), and has also been associated with Both Cyclospora and Isospora belongs to family diarrhea outbreaks in mental wards and day care centers Eimeridae, subphylum apicomplexa, which are (Marshall et al.
    [Show full text]
  • The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels Among Women in Childbearing Age in Kirkuk Province-Iraq
    Open Journal of Medical Microbiology, 2019, 9, 151-167 https://www.scirp.org/journal/ojmm ISSN Online: 2165-3380 ISSN Print: 2165-3372 The Impact of Toxoplasma gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age in Kirkuk Province-Iraq Faten Ayoob Tayeb1, Yahay Jirjees Salman2*, Khalidha Mohammad Ameen3 1Biology Department, M.Sc. College of Science-Kirkuk University, Kirkuk, Iraq 2Department of Medical Microbiology and Immunology, Ph.D. Microbiology, Kirkuk Medical College, Kirkuk, Iraq 3Department of Gynecology and Obstetric-Kirkuk Medical College, Ph.D. Gynecology and Obstetric, Kirkuk Medical College, Kirkuk, Iraq How to cite this paper: Tayeb, F.A., Sal- Abstract man, Y.J. and Ameen, K.M. (2019) The Impact of Toxoplasma gondii Infection on Background: Toxoplasmosis had a remarked role in disturbing pregnancy in the Vitamin D3 Levels among Women in women by abortions and congenital abnormalities outcome .Vitamin D defi- Childbearing Age in Kirkuk Province-Iraq. ciency had a role in bone fragility, osteoporosis, exposing women to fractures Open Journal of Medical Microbiology, 9, as well as to bone deformities in newborns. Objective: To assess the rela- 151-167. https://doi.org/10.4236/ojmm.2019.94015 tionship between toxoplasmosis seropositivity and vitamin D abnormalities in sera of women in childbearing ages using ELISA and auto-analyzers. Me- Received: September 5, 2019 thodology: A cross-sectional study was conducted by examining the sera of Accepted: November 29, 2019 153 women, who visited Azadi Teaching Hospital Gynecological and Obste- Published: December 2, 2019 tric Clinics. Their complaints involve signs of bad obstetric history (BOH) Copyright © 2019 by author(s) and and bone disorders, versus to 46 women negative for (BOH).
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]